These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2219584)

  • 1. Flow cytometry in carcinoma of the prostate.
    Benson MC; Ring K; Giella J
    Urol Clin North Am; 1990 Nov; 17(4):885-91. PubMed ID: 2219584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of flow cytometry and automated image analysis to the study of prostate cancer.
    Benson MC
    NCI Monogr; 1988; (7):25-9. PubMed ID: 3050538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consensus review of the clinical utility of DNA content cytometry in prostate cancer.
    Shankey TV; Kallioniemi OP; Koslowski JM; Lieber ML; Mayall BH; Miller G; Smith GJ
    Cytometry; 1993; 14(5):497-500. PubMed ID: 8354122
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical utility of cellular DNA measurements in prostate carcinoma. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993.
    Schröder F; Tribukait B; Böcking A; DeVere White R; Koss L; Lieber M; Stenkvist B; Zetterberg A
    Scand J Urol Nephrol Suppl; 1994; 162():51-63; discussion 15-27. PubMed ID: 7529429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Flow cytometry in prostate cancer. Evaluation of its feasibility for biopsy specimens and correlation with grading].
    Ferrara G; Monaco R; Capasso A; Bellomo PF; Fruttero A; Pugno F; Nappi O; Ruà S
    Pathologica; 1998 Feb; 90(1):14-9. PubMed ID: 9628974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The prognostic value of flow cytometry in prostatic cancer].
    Matveev BP; Bukharkin BV; Bogatyrev VN; Iurasova IV; Ataev AA; Bocharova OA; Mustia AI
    Urol Nefrol (Mosk); 1994; (4):24-7. PubMed ID: 7985295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
    Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
    Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometry in prostate cancer: histological and clinical correlation.
    de Leval L; Waltregny D; Greimers R; Boniver J
    Acta Urol Belg; 1994 Apr; 62(1):37-43. PubMed ID: 8197928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Flow cytometry studies of the DNA content and proliferation kinetics of human tumors].
    Baisch H
    Strahlentherapie; 1984 Jul; 160(7):431-5. PubMed ID: 6464047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metaphase cytogenetics and DNA flow cytometry with analysis of S-phase fraction in prostate cancer: influence on prognosis.
    Bratt O; Anderson H; Bak-Jensen E; Baldetorp B; Lundgren R
    Urology; 1996 Feb; 47(2):218-24. PubMed ID: 8607238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Near tetraploid prostate carcinoma. Methodologic and prognostic aspects.
    Forsslund G; Nilsson B; Zetterberg A
    Cancer; 1996 Oct; 78(8):1748-55. PubMed ID: 8859188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Importance of impulse cytophotometry in the diagnosis and prognosis of prostate cancer].
    Zimmermann A; Truss F; Blech M; Schröter W; Barth M
    Urologe A; 1983 May; 22(3):151-6. PubMed ID: 6192580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA content of prostatic cancer measured by flow cytometry in patients undergoing radical prostatectomy.
    Romics I; Bocsi J; Bach D; Beutler W; Frang D; Kopper L
    Anticancer Res; 1995; 15(3):1131-4. PubMed ID: 7645937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative nuclear morphometry, Markovian texture descriptors, and DNA content captured on a CAS-200 Image analysis system, combined with PCNA and HER-2/neu immunohistochemistry for prediction of prostate cancer progression.
    Veltri RW; Partin AW; Epstein JE; Marley GM; Miller CM; Singer DS; Patton KP; Criley SR; Coffey DS
    J Cell Biochem Suppl; 1994; 19():249-58. PubMed ID: 7529856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow cytometry: methodology and applications in pathology.
    Quirke P; Dyson JE
    J Pathol; 1986 Jun; 149(2):79-87. PubMed ID: 2426431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thin-needle aspiration biopsy of the prostate.
    Koss LG; Woyke S; Schreiber K; Kohlberg W; Freed SZ
    Urol Clin North Am; 1984 May; 11(2):237-51. PubMed ID: 6203204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA ploidy and proliferation heterogeneity in human prostate cancers.
    Shankey TV; Jin JK; Dougherty S; Flanigan RC; Graham S; Pyle JM
    Cytometry; 1995 Sep; 21(1):30-9. PubMed ID: 8529468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of prognostic factors in men undergoing radical prostatectomy for adenocarcinoma of the prostate, including DNA ploidy, surgical tumor stage, prostatic specific antigen, Gleason grade, and age.
    Shockley KF; Maatman TJ; Carothers GC; Warzynski MJ
    Prostate; 1996 Jul; 29(1):46-50. PubMed ID: 8685055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro detection of prostate cancer circulating cells by immunocytochemistry, flow cytometry and RT-PCR PSA].
    de la Taille A; Muscatelli B; Colombel M; Jouault H; Amsellem S; Mazeman E; Abbou CC; Chopin D
    Prog Urol; 1998 Dec; 8(6):1058-64. PubMed ID: 9894270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometric analysis of androgen receptor expression in human prostate tumors and benign tissues.
    Krishan A; Oppenheimer A; You W; Dubbin R; Sharma D; Lokeshwar BL
    Clin Cancer Res; 2000 May; 6(5):1922-30. PubMed ID: 10815917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.